(Raleigh, NC) -- ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Ozyme as its new distributor in France.
ImmunoReagents and Ozyme will partner to distribute top quality antibodies and reagents to the French biotech, life science, and medical communities. Over the last two decades, France has become a major player in the European biotechnology sector. With over 300 biotech firms and more than 600 biotechnology service and support companies France ranks among the top biotech nations in Europe. Quoting the Organization for Economic Cooperation and Development, France’s biotech sector ranked second worldwide last year, with 1,359 firms.
"This is an exciting opportunity for our company." said Ann Black, President and CEO of ImmunoReagents. "Our partnership with Ozyme will allow us to bring our products to one of the world’s most vibrant biotech markets.”
About ImmunoReagents
ImmunoReagents, Inc. is a leading global manufacturer of quality antibodies and reagents used in pharmaceutical research, life science research and in vitro diagnostics. Product offerings include a wide range of immunochemistry reagents such as purified immunoglobulins, primary antibodies, and secondary antibodies covering a broad spectrum of immunoglobulins from various species. ImmunoReagents also provides custom manufacturing to meet specific customer requirements while adhering to cGMP guidelines and ISO quality systems requirements. The company is located in Raleigh, North Carolina
More information about ImmunoReagents: www.immunoreagents.com
About Ozyme
Since 1984, Ozyme has supplied top laboratories with research products. Ozyme selects and offers products from the best names in cell biology, immunology, and molecular biology. Based in the Paris region, the Ozyme team is composed of 36 employees including 20 scientists that are committed to providing top-level support. Ozyme is focused on its core value: the commitment and competence of women and men who drive it.
More information about Ozyme: http://www.ozyme.fr
